INVESTOR RESOURCES

Quick Links

CORPORATE PRESENTATION

We invite you to download our corporate presentation to help understand our unique purpose, our current commercial footprint, and our innovative pipeline.

DOWNLOAD OUR CORPORATE PRESENTATION

DOWNLOAD OUR QUARTERLY FACTSHEET

Quarterly Results

2024

Third Quarter

Type	Title	Interactions
Webcast	United Therapeutics Third Quarter 2024 Financial Results	Link
Press Release	United Therapeutics Corporation Reports Third Quarter 2024 Financial Results	Link PDF
SEC Filing	Form 10-Q	PDF
Presentation	United Therapeutics Third Quarter 2024 Financial Results Presentation	PDF
Factsheet	United Therapeutics Third Quarter 2024 Factsheet	PDF

Second Quarter

Type	Title	Interactions
Webcast	United Therapeutics Second Quarter 2024 Financial Results	Link
Press Release	United Therapeutics Corporation Reports Second Quarter 2024 Financial Results	Link PDF
SEC Filing	Form 10-Q	PDF
Presentation	United Therapeutics Second Quarter 2024 Financial Results Presentation	PDF

First Quarter

Type	Title	Interactions
Webcast	United Therapeutics First Quarter 2024 Financial Results	Link
Press Release	United Therapeutics Corporation Reports First Quarter 2024 Financial Results	Link PDF
SEC Filing	Form 10-Q	PDF
Presentation	United Therapeutics First Quarter 2024 Financial Results Presentation	PDF

2023

Fourth Quarter

Type	Title	Interactions
Webcast	United Therapeutics Fourth Quarter 2023 Financial Results	Link
Press Release	United Therapeutics Corporation Reports Fourth Quarter 2023 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF
Presentation	United Therapeutics Fourth Quarter 2023 Financial Results Presentation	PDF

Third Quarter

Type	Title	Interactions
Webcast	United Therapeutics Third Quarter 2023 Financial Results	Link
Press Release	United Therapeutics Corporation Reports Third Quarter 2023 Financial Results	Link PDF
SEC Filing	Form 10-Q	PDF
Presentation	United Therapeutics Third Quarter 2023 Financial Results Presentation	PDF

Second Quarter

Type	Title	Interactions
Webcast	United Therapeutics Second Quarter 2023 Financial Results	Link
Press Release	United Therapeutics Corporation Reports Second Quarter 2023 Financial Results	Link PDF
SEC Filing	Form 10-Q	PDF

First Quarter

Type	Title	Interactions
Webcast	United Therapeutics First Quarter 2023 Financial Results	Link
Press Release	United Therapeutics Corporation Reports First Quarter 2023 Financial Results	Link PDF
SEC Filing	Form 10-Q	PDF

2022

Fourth Quarter

Type	Title	Interactions
Webcast	United Therapeutics Fourth Quarter 2022 Financial Results	Link
Press Release	United Therapeutics Corporation Reports Fourth Quarter 2022 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Third Quarter

Type	Title	Interactions
Webcast	United Therapeutics Third Quarter 2022 Financial Results	Link
Press Release	United Therapeutics Corporation Reports Third Quarter 2022 Financial Results	Link PDF
SEC Filing	Form 10-Q	PDF

Second Quarter

Type	Title	Interactions
Webcast	United Therapeutics Second Quarter 2022 Financial Results	Link
Press Release	United Therapeutics Corporation Reports Second Quarter 2022 Financial Results	Link PDF
SEC Filing	Form 10-Q	PDF

First Quarter

Type	Title	Interactions
Webcast	United Therapeutics First Quarter 2022 Financial Results	Link
Press Release	United Therapeutics Corporation Reports First Quarter 2022 Financial Results	Link PDF
SEC Filing	Form 10-Q	PDF

2021

Fourth Quarter

Type	Title	Interactions
Webcast	United Therapeutics Fourth Quarter 2021 Financial Results	Link
Press Release	United Therapeutics Corporation Reports Fourth Quarter 2021 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Third Quarter

Type	Title	Interactions
Webcast	United Therapeutics Third Quarter 2021 Financial Results	Link
Press Release	United Therapeutics Corporation Reports Third Quarter 2021 Financial Results	Link PDF
SEC Filing	Form 10-Q	PDF

Second Quarter

Type	Title	Interactions
Webcast	United Therapeutics Second Quarter 2021 Financial Results	Link
Press Release	United Therapeutics Corporation Reports Second Quarter 2021 Financial Results	Link PDF
SEC Filing	Form 10-Q	PDF

First Quarter

Type	Title	Interactions
Webcast	United Therapeutics First Quarter 2021 Financial Results	Link
Press Release	United Therapeutics Corporation Reports First Quarter 2021 Financial Results	Link PDF
SEC Filing	Form 10-Q	PDF

2020

Fourth Quarter

Type	Title	Interactions
Webcast	United Therapeutics Fourth Quarter 2020 Financial Results	Link
Press Release	United Therapeutics Corporation Reports Fourth Quarter 2020 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Third Quarter

Type	Title	Interactions
Webcast	United Therapeutics Third Quarter 2020 Financial Results	Link
Press Release	United Therapeutics Corporation Reports Fourth Quarter 2020 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Second Quarter

Type	Title	Interactions
Webcast	United Therapeutics Second Quarter 2020 Financial Results	Link
Press Release	United Therapeutics Corporation Reports Second Quarter 2020 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

First Quarter

Type	Title	Interactions
Webcast	United Therapeutics First Quarter 2020 Financial Results	Link
Press Release	United Therapeutics Corporation Reports First Quarter 2020 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

2019

Fourth Quarter

Type	Title	Interactions
Webcast	United Therapeutics Fourth Quarter 2019 Financial Results	Link
Press Release	United Therapeutics Corporation Reports Fourth Quarter and Full Year 2019 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Third Quarter

Type	Title	Interactions
Webcast	United Therapeutics Third Quarter 2019 Financial Results	Link
Press Release	United Therapeutics Corporation Reports Third Quarter 2019 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Second Quarter

Type	Title	Interactions
Webcast	United Therapeutics Second Quarter 2019 Financial Results	Link
Press Release	United Therapeutics Corporation Reports Second Quarter 2019 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

First Quarter

Type	Title	Interactions
Webcast	United Therapeutics First Quarter 2019 Financial Results	Link
Press Release	United Therapeutics Corporation Reports First Quarter 2019 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

2018

Fourth Quarter

Type	Title	Interactions
Webcast	United Therapeutics Fourth Quarter 2018 Financial Results	Link
Press Release	United Therapeutics Corporation Reports 2018 Fourth Quarter And Annual Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Third Quarter

Type	Title	Interactions
Webcast	United Therapeutics Third Quarter 2018 Financial Results	Link
Press Release	United Therapeutics Corporation Reports Third Quarter 2018 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Second Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Second Quarter 2018 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

First Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports First Quarter 2018 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

2017

Fourth Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Second Quarter 2017 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Third Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Third Quarter 2017 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Second Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Second Quarter 2017 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

First Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Second Quarter 2017 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

2016

Fourth Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Second Quarter 2017 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Third Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Third Quarter 2016 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Second Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Second Quarter 2018 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

First Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports First Quarter 2018 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

2015

Fourth Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Fourth Quarter 2015 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Third Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Third Quarter 2015 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Second Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Second Quarter 2015 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

First Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports First Quarter 2015 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

2014

Fourth Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Fourth Quarter 2014 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Third Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Third Quarter 2014 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Second Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Second Quarter 2014 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

First Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports First Quarter 2014 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

2013

Fourth Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Fourth Quarter 2013 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Third Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Third Quarter 2013 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Second Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Second Quarter 2013 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

First Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports First Quarter 2013 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

2012

Fourth Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Fourth Quarter 2012 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Third Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Third Quarter 2012 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Second Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Second Quarter 2012 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

First Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports First Quarter 2012 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

2011

Fourth Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Fourth Quarter 2011 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Third Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Third Quarter 2011 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Second Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Second Quarter 2011 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

First Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports First Quarter 2011 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

2010

Fourth Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Fourth Quarter 2010 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Third Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Third Quarter 2010 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Second Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Second Quarter 2010 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

First Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports First Quarter 2010 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

2009

Fourth Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Fourth Quarter 2009 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Third Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Third Quarter 2009 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Second Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Second Quarter 2009 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

First Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports First Quarter 2009 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

2008

Fourth Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Fourth Quarter 2008 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Third Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Third Quarter 2008 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Second Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Second Quarter 2008 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

First Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports First Quarter 2008 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

2007

Fourth Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Fourth Quarter 2007 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Third Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Third Quarter 2007 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Second Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Second Quarter 2007 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

First Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports First Quarter 2007 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

2006

Fourth Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Fourth Quarter 2006 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Third Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Third Quarter 2006 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

Second Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Second Quarter 2006 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

First Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports First Quarter 2006 Financial Results	Link PDF
SEC Filing	Form 10-K	PDF

2005

Fourth Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Fourth Quarter 2005 Financial Results	PDF
SEC Filing	Form 10-K	Link

Third Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Third Quarter 2005 Financial Results	PDF
SEC Filing	Form 10-K	PDF

Second Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Second Quarter 2005 Financial Results	PDF
SEC Filing	Form 10-K	PDF

First Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports First Quarter 2005 Financial Results	PDF
SEC Filing	Form 10-K	PDF

2004

Fourth Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Fourth Quarter 2004 Financial Results	PDF
SEC Filing	Form 10-K	PDF

Third Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Third Quarter 2004 Financial Results	PDF
SEC Filing	Form 10-K	PDF

Second Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports Second Quarter 2004 Financial Results	PDF
SEC Filing	Form 10-K	PDF

First Quarter

Type	Title	Interactions
Press Release	United Therapeutics Corporation Reports First Quarter 2004 Financial Results	PDF
SEC Filing	Form 10-K	PDF

view all

Press Releases

21 Jan 2025

United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the Pulmonary Vascular Research Institute 2025 Annual Congress

Posters include real-world dosing of Tyvaso DPI® in pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease, and data from the BREEZE open-label extension study of Tyvaso DPI...

Download pdf

06 Jan 2025

United Therapeutics Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Dr. Martine Rothblatt, Chairperson and Chief...

Download pdf

17 Dec 2024

United Therapeutics Announces Successful World’s First UKidney Transplant

The first living recipient of a UKidney™ is recovering after a successful transplantThis transplant builds on two successful UHeart™ transplants completed in 2022 and 2023 and a successful UThymoKidney™ transplant in...

Download pdf

05 Nov 2024

United Therapeutics Corporation to Present at the UBS Global Healthcare Conference

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Patrick Poisson, Executive Vice President...

Download pdf

30 Oct 2024

United Therapeutics Corporation Reports Third Quarter 2024 Financial Results

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended September...

Download pdf

23 Oct 2024

United Therapeutics Corporation Announces the 500th Lung Transplant Utilizing its Centralized Ex Vivo Lung Perfusion Service

Unique centralized service helps increase the supply of lungs for transplant, addressing a critical unmet needSILVER SPRING, Md. & JACKSONVILLE, Fla.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR),...

Download pdf

view all

Events and presentations

13 Jan 2025

J.P. Morgan Healthcare Conference

05:15 PM ET

Listen to webcast Download Presentation PDF

12 Nov 2024

UBS Global Healthcare Conference

05:45 PM ET

Listen to webcast

30 Oct 2024

United Therapeutics Third Quarter 2024 Financial Results

09:00 AM ET

Listen to webcast Download Presentation PDF Download Fact Sheet PDF

31 Jul 2024

United Therapeutics Second Quarter 2024 Financial Results

09:00 AM ET

Listen to webcast Download pdf

01 May 2024

United Therapeutics First Quarter 2024 Financial Results

09:00 AM ET

Listen to webcast Download pdf

21 Feb 2024

United Therapeutics Fourth Quarter 2023 Financial Results

09:00 AM ET

Listen to webcast Download pdf

view all

INVESTOR RESOURCES

CORPORATE PRESENTATION

Quarterly Results

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

Press Releases

Events and presentations

SEC Filings

Corporate Annual Reports

PROXY STATEMENTS